Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness

NCT00605410 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: ipratropium bromide
DRUG: placebo

Sponsor

University of Saskatchewan

Collaborators

[object Object]